Home > Insider Trading > Filing (0001415889-24-009473)

Filing Details

Accession Number:: 0001415889-24-009473
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-29 21:35:12
Reporting Period:: 2024-03-15

Accepted Time:: 2024-03-29 21:35:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604821	Natera Inc.	NTRA	Services-Medical Laboratories (8071)	010894487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1711968	Leonard Steven Chapman	C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753	Ceo And President	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-03-15	10,265	$87.98	40,645	No	4	S	Indirect	By Chapman Family Trust
Common Stock	Disposition	2024-03-15	20,575	$88.97	20,070	No	4	S	Indirect	By Chapman Family Trust
Common Stock	Disposition	2024-03-15	20,070	$89.60	0	No	4	S	Indirect	By Chapman Family Trust
Common Stock	Acquisiton	2024-03-27	5,184	$0.00	237,188	No	4	M	Direct
Common Stock	Disposition	2024-03-28	2,662	$90.42	234,526	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Chapman Family Trust
No	4	S	Indirect	By Chapman Family Trust
No	4	S	Indirect	By Chapman Family Trust
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2024-03-27	5,184	$0.00	5,184	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.4050 to $88.40 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 50,910 shares previously reported as owned indirectly by the Rosewood Trust.
The Reporting Person is a trustee of the Chapman Family Trust and has voting and dispositive power with respect to the reported shares. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.4050 to $89.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.4050 to $89.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on March 27, 2020.
The RSUs vest over four years. 25% of the RSUs vested on March 27, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter.